Pharm Country

Found 130,510 articles

• Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors

  3/20/2023

  Waters Corporation introduced Alliance iS, the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error detection, troubleshooting and ease-of-use.

• Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology

  3/20/2023

  Timber Pharmaceuticals, Inc today announced the online publication of a sub-analysis of the Phase 2b CONTROL study in Clinical and Experimental Dermatology (CED), the educational journal of the British Association of Dermatologists.

• Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO - March 20, 2023

  3/20/2023

  Tiziana Life Sciences Ltd. announces that it has been notified that Gabriele Cerrone, its Chairman and Acting Chief Executive Officer, purchased 45,000 common shares at $0.66 per share, bringing his total holding to 38,685,737 common shares.

• Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business Update

  3/20/2023

  Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today provided a corporate and financial update for the fourth quarter and full year ended December 31, 2022.

• PaxMedica Holds Meeting of Scientific Advisory Board

  3/20/2023

  PaxMedica, Inc. today announced that it held a Scientific Advisory Board meeting on March 10-12, 2023. 

• Genes that Form Specific Bones In the Womb Heal them Later in Life

  3/20/2023

  Genes long known to control the formation of bones before birth also control bone healing later in life, a new study found.

• Techdow USA Announces FDA Approval of Generic Lovenox®, (Enoxaparin Sodium – Preservative Free) In Prefilled Syringes

  3/20/2023

  Techdow USA Inc. (“Techdow USA”), a growing market leader and vertically integrated generic injectables company, today announced the FDA approval of Enoxaparin Sodium (Preservative Free) in Prefilled Syringes for the U.S. market.

• Dirk Bontridder Appointed as CEO of New PerkinElmer Business Acquired by New Mountain Capital

  3/20/2023

  The new PerkinElmer business acquired by New Mountain Capital announced today the appointment of Dirk Bontridder as Chief Executive Officer effective March 13, 2023.

• Synchron to Begin Patient Enrollment for the COMMAND Trial of Brain-Computer Interface at Gates Vascular Institute

  3/20/2023

  Synchron today announced the COMMAND trial is commencing at Gates Vascular Institute, a Kaleida Health facility in Buffalo, N.Y. and teaching affiliate of the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB).

• FORE Biotherapeutics Receives FDA Orphan Drug Designation for FORE8394 for the Treatment of Primary Brain and CNS Malignancies

  3/20/2023

  FORE Biotherapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead program, FORE8394, for the treatment of primary brain and central nervous system (CNS) malignancies.

• Dante Genomics launches Avanti Software for a plug-and-play genomic interpretation that takes minutes instead of hours

  3/20/2023

  Dante Genomics , a global leader in genomics and precision medicine, launched today the beta version of Avanti, the Company's proprietary B2B software for variant interpretation and report writing at scale.

• DolCas Biotech and Clear Within Team Up for Beauty-from-Within Supplement

  3/20/2023

  DolCas Biotech, LLC and its concentrated turmeric extract, Curcugen®, have been selected by nutritional supplement company, Clear Within, for its vegan nutricosmetic.

• Quest Diagnostics Completes Acquisition of Northern Light Laboratory in Maine

  3/20/2023

  Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of select assets of Northern Light Laboratory, the outreach laboratory services business of Northern Light Health, a large integrated healthcare system in Maine.

• New York Doctor Successfully Treats Autoimmune Diseases with Game-Changing Cellular Therapy

  3/20/2023

  Dr. Raphael Kellman, MD is successfully treating autoimmune diseases through Cellular Therapy, an innovative and cutting-edge therapy using the body's own cells.

• Cure Rare Disease Welcomes Leading Experts to Scientific Advisory Board

  3/20/2023

  Cure Rare Disease (CRD) - a nonprofit biotechnology company focused on developing treatments for ultra-rare diseases - announces the appointment of leading experts in the fields of gene therapy and neuromuscular disorders to its Scientific Advisory Board (SAB).

• Patritumab Deruxtecan Continues to Show Encouraging Clinical Activity in Distinct Patient Populations with Metastatic Lung and Breast Cancer in Updated Results of Two Early Trials

  3/20/2023

  New data from Daiichi Sankyo’s patritumab deruxtecan from two early trials in patients with previously treated EGFR-mutated metastatic non-small cell lung cancer or HER3 expressing metastatic breast cancer were presented during two Presidential Sessions at the Japanese Society of Medical Oncology Annual Meeting.

• Xalud Therapeutics Presents Clinical Data on XT-150 in Knee Osteoarthritis at the 2023 Osteoarthritis Research Society International World Congress

  3/20/2023

  Xalud Therapeutics, a clinical-stage biotechnology company developing novel non-viral gene therapies to treat pathologic inflammation, today announced pooled gait data from a world-renowned gait laboratory in Adelaide, Australia, which served as a study site for two studies of lead candidate XT-150 in patients with knee osteoarthritis (OA).

• RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Commercial Update

  3/20/2023

  RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced financial results and business highlights for the three months and full year ended December 31, 2022.

• Syft Technologies Announces Commercial Release of Next Generation SIFT-MS, Syft Tracer™

  3/20/2023

  Syft Technologies announced the release of its next generation Selected Ion Flow Tube Mass Spectrometry technology, Syft Tracer™, at Pittcon 2023.

• Mitsubishi Tanabe Pharma America to Share ALS Research at AMCP Annual Meeting 2023

  3/20/2023

  Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of one poster describing real-world findings with RADICAVA® (edaravone) in amyotrophic lateral sclerosis (ALS) at the Academy of Managed Care Pharmacy (AMCP) annual meeting, being held in San Antonio, Tex., March 21-24.